Anti-tachycardia Pacing: Mechanism, History and Contemporary Implementation
S Panchangam, KM Monahan, RH Helm - Current Treatment Options in …, 2022 - Springer
Abstract Purpose of Review Implantable cardioverter-defibrillator (ICD) shocks, whether
appropriate or inappropriate, are associated with significant morbidity and mortality. Anti …
appropriate or inappropriate, are associated with significant morbidity and mortality. Anti …
Antitachycardia pacing for reduction of implantable cardioverter-defibrillator shocks
DJ Cantillon, BL Wilkoff - Heart Rhythm, 2015 - Elsevier
Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …
Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
SS Awad, EF Azeez, MO Taha, WM El-Naggar… - The Egyptian Heart …, 2023 - Springer
Background Anti-tachycardia pacing therapy (ATP) has shown comparable efficacy to shock
therapy in ventricular tachycardia (VT) termination with better quality of life. However, some …
therapy in ventricular tachycardia (VT) termination with better quality of life. However, some …
Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial
M Saeed, CG Neason, M Razavi… - Journal of …, 2010 - Wiley Online Library
Programming ATP for ICD Patients. Objectives: The PROVE trial was designed to determine
if antitachycardia pacing (ATP) is clinically beneficial for primary prevention in patients who …
if antitachycardia pacing (ATP) is clinically beneficial for primary prevention in patients who …
[HTML][HTML] Antitachycardia pacing success in implantable cardioverter-defibrillators by patient, device, and programming characteristics
LD Sterns, A Auricchio, EJ Schloss, D Lexcen… - Heart Rhythm, 2023 - Elsevier
Background Antitachycardia pacing (ATP) is an established implantable cardioverter-
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
defibrillator (ICD) therapy that terminates ventricular tachycardias (VTs) without painful ICD …
Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable …
MS Wathen, PJ DeGroot, MO Sweeney, AJ Stark… - Circulation, 2004 - Am Heart Assoc
Background—Successful antitachycardia pacing (ATP) terminates ventricular tachycardia
(VT) up to 250 bpm without the need for painful shocks in implantable cardioverter …
(VT) up to 250 bpm without the need for painful shocks in implantable cardioverter …
915 ATP efficacy on terminating ventricular tachycardia by device type, indication, and ventricular median cycle length
M Brown, T Kurita, LD Sterns, EJ Schloss… - EP …, 2020 - academic.oup.com
Abstract Funding Acknowledgements Medtronic OnBehalf PainFree SST Background Anti-
tachycardia Pacing (ATP) is an established therapy that terminates VT without the need for …
tachycardia Pacing (ATP) is an established therapy that terminates VT without the need for …
Efficacy of Anti-Tachycardia Pacing for Terminating Fast Ventricular Tachycardia in Japanese Implantable Cardioverter Defibrillator Patients–Primary Results of the …
T Watanabe, K Inoue, K Kashiwase, T Mine… - Circulation …, 2014 - jstage.jst.go.jp
Background: Anti-tachycardia pacing (ATP) delivered by implantable cardioverter
defibrillators (ICD) safely avoids painful shocks with minimum risk of tachycardia …
defibrillators (ICD) safely avoids painful shocks with minimum risk of tachycardia …
Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging
W Schoels, D Steinhaus, WB Johnson, G O'Hara… - Heart Rhythm, 2007 - Elsevier
BACKGROUND: Previous studies in implantable cardioverter-defibrillator (ICD) patients
demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular …
demonstrated the efficacy and safety of antitachycardia pacing (ATP) for rapid ventricular …
Antitachycardia pacing for termination of ventricular tachyarrhythmias: should we use it?
AC Ruwald, JP Daubert - EP Europace, 2015 - academic.oup.com
The first implantable cardioverter-defibrillator (ICD) device was developed by Drs Michel
Mirowski and Morty Mower, and successfully implanted in a human being at John Hopkins …
Mirowski and Morty Mower, and successfully implanted in a human being at John Hopkins …